Skip to content

Clinical study on the effect of ''lying-sitting-standing'' sequential Baduanjin on cardiac rehabilitation in patients with acute myocardial infarction after PCI

Clinical study on the effect of ''lying-sitting-standing'' sequential Baduanjin on cardiac rehabilitation in patients with acute myocardial infarction after PCI

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300071294
Enrollment
Unknown
Registered
2023-05-10
Start date
2023-06-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction

Interventions

Experimental group:Routine treatment and care, ''lying-sitting-standing'' sequential Baduanjin

Sponsors

Intensive Care Unit, Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-70 years; 2. Patients diagnosed with AMI after PCI; 3. Muscle strength >=3; 4. No history of mental illness, clear consciousness, can voluntarily cooperate with this study; 5. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating patients; 2. Patients with active myocardial ischemia or cardiogenic shock, severe heart failure (grade IV heart function, or left ventricular ejection fraction =100bpm; 4. Poor hypertension control, systolic blood pressure >=180mmHg and/or diastolic blood pressure >=100mmHg; 5. Severe blood system diseases; 6. Patients with malignant tumors; 7. Patients with active bleeding; 8. Poor compliance, activity intolerance; 9. Patients with poor basic conditions, such as those with mobility difficulties and physical incapacity due to diseases of the bone and joint system and nervous system diseases, so as to avoid fractures or aggravation of heart failure due to falls; 10. Participate in other studies.

Design outcomes

Primary

MeasureTime frame
Left ventricular ejection fractions;

Secondary

MeasureTime frame
Fasting blood glucose;Blood pressure;TCM syndrome score scale;NT-proBNP;Exosomes miRNA;Echocardiography;6-minute walking test;Cardiopulmonary exercise testing;

Countries

China

Contacts

Public ContactZhang Xiaoxuan

Intensive Care Unit, Guangdong Provincial Hospital of Traditional Chinese Medicine

20211120731@stu.gzucm.edu.cn+86 139 2246 8632

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026